AR033748A1 - Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo - Google Patents

Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo

Info

Publication number
AR033748A1
AR033748A1 ARP020101791A ARP020101791A AR033748A1 AR 033748 A1 AR033748 A1 AR 033748A1 AR P020101791 A ARP020101791 A AR P020101791A AR P020101791 A ARP020101791 A AR P020101791A AR 033748 A1 AR033748 A1 AR 033748A1
Authority
AR
Argentina
Prior art keywords
active substances
procedure
transdermal administration
pharmacologically active
prepare
Prior art date
Application number
ARP020101791A
Other languages
English (en)
Inventor
Francisco Jose Evaristo Stefano
Alejandro Fabio Scasso
Original Assignee
Thalas Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thalas Group Inc filed Critical Thalas Group Inc
Priority to ARP020101791A priority Critical patent/AR033748A1/es
Priority to AU2003230032A priority patent/AU2003230032A1/en
Priority to MXPA04011214A priority patent/MXPA04011214A/es
Priority to PCT/GB2003/002118 priority patent/WO2003097020A1/en
Priority to PCT/GB2003/002120 priority patent/WO2003097008A2/en
Priority to AT03722872T priority patent/ATE352294T1/de
Priority to ES03722872T priority patent/ES2281641T3/es
Priority to US10/514,047 priority patent/US8017146B2/en
Priority to AU2003230034A priority patent/AU2003230034A1/en
Priority to EP03722872A priority patent/EP1503743B1/en
Priority to DE60311449T priority patent/DE60311449T2/de
Publication of AR033748A1 publication Critical patent/AR033748A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Abstract

Un dispositivo para la administración transdérmica de sustancias farmacológicamente activas que comprende dos capas adhesivas superpuesta en el cual la primera capa está compuesta por un adhesivo sensible a la presión y la segunda capa está compuesta por un adhesivo o por una mezcla de adhesivos sensibles a la presión y en las cuales una o más sustancias activas se encuentran disueltas, porque cada una de las capas presenta una composición adhesiva diferentes y una afinidad diferente por la o las sustancias activas y porque cada capa adhesiva posee un grado de saturación similar y menor al 100%. Un procedimiento para la manufactura de dicho dispositivo.
ARP020101791A 2002-05-15 2002-05-15 Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo AR033748A1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ARP020101791A AR033748A1 (es) 2002-05-15 2002-05-15 Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
AU2003230032A AU2003230032A1 (en) 2002-05-15 2003-05-15 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
MXPA04011214A MXPA04011214A (es) 2002-05-15 2003-05-15 Sistema de adminsitracion transdermica con dos capas adhesivas superpuestas que tienen afinidades diferentes por la sustancia activa incluida.
PCT/GB2003/002118 WO2003097020A1 (en) 2002-05-15 2003-05-15 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
PCT/GB2003/002120 WO2003097008A2 (en) 2002-05-15 2003-05-15 Transdermal delivery device for the administration of fentanyl
AT03722872T ATE352294T1 (de) 2002-05-15 2003-05-15 Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen
ES03722872T ES2281641T3 (es) 2002-05-15 2003-05-15 Sistema de administracion transdermica con dos capas adhesivas superpuestas que tienen diferente afinidad por la sustancia activa.
US10/514,047 US8017146B2 (en) 2002-05-15 2003-05-15 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
AU2003230034A AU2003230034A1 (en) 2002-05-15 2003-05-15 Transdermal delivery device for the administration of fentanyl
EP03722872A EP1503743B1 (en) 2002-05-15 2003-05-15 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
DE60311449T DE60311449T2 (de) 2002-05-15 2003-05-15 Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP020101791A AR033748A1 (es) 2002-05-15 2002-05-15 Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo

Publications (1)

Publication Number Publication Date
AR033748A1 true AR033748A1 (es) 2004-01-07

Family

ID=38561712

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101791A AR033748A1 (es) 2002-05-15 2002-05-15 Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo

Country Status (9)

Country Link
US (1) US8017146B2 (es)
EP (1) EP1503743B1 (es)
AR (1) AR033748A1 (es)
AT (1) ATE352294T1 (es)
AU (1) AU2003230032A1 (es)
DE (1) DE60311449T2 (es)
ES (1) ES2281641T3 (es)
MX (1) MXPA04011214A (es)
WO (1) WO2003097020A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) † 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
WO2007095147A2 (en) * 2006-02-13 2007-08-23 Aveva Drug Delivery Systems Adhesive preparation comprising sufentanil and methods of using the same
DE102006054733A1 (de) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
WO2008083034A1 (en) * 2006-12-27 2008-07-10 Nexagen Usa, Llc Transdermal vitamin b12 delivery patch
WO2008093772A1 (ja) * 2007-01-31 2008-08-07 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
CN104398496B (zh) * 2007-10-15 2018-03-20 阿尔扎公司 芬太尼的一天更换一次透皮施用
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
PL2552245T3 (pl) 2010-03-26 2019-05-31 Philip Morris Products Sa Inhibicja podrażnienia sensorycznego podczas konsumpcji produktów tytoniowych niepalnych
US8481560B2 (en) * 2010-04-02 2013-07-09 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
JP6188933B2 (ja) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
WO2015054058A1 (en) * 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Dexmedetomidine Transdermal Delivery Devices and Methods for Using the Same
JP6310070B2 (ja) 2013-10-07 2018-04-11 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を用いる、注意欠陥多動性障害、不安症及び不眠症の治療法及び組成物
JP6940407B2 (ja) * 2014-12-19 2021-09-29 キンデーバ ドラッグ デリバリー リミティド パートナーシップ フェンタニルを含む経皮薬物送達デバイス
WO2018089335A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
KR20220163495A (ko) * 2017-06-08 2022-12-09 애프리컷 지엠비에이치 피부 관리 및 피부 노화 방지를 위한 활성 물질이 포함된 실리콘 패드

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4436741A (en) 1975-12-08 1984-03-13 Alza Corporation Method for administering scopolamine transdermally
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US5310559A (en) 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4906463A (en) 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5006342A (en) 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4223360C1 (es) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
DE19527925C2 (de) 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
CA2331264C (en) 1999-01-14 2008-09-23 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
KR20010036685A (ko) * 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
FR2801507B1 (fr) 1999-11-30 2003-06-27 Pf Medicament Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
AU2003268376A1 (en) 2002-08-30 2004-11-26 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods

Also Published As

Publication number Publication date
EP1503743A1 (en) 2005-02-09
DE60311449T2 (de) 2007-11-08
AU2003230032A1 (en) 2003-12-02
ES2281641T3 (es) 2007-10-01
DE60311449D1 (de) 2007-03-15
ATE352294T1 (de) 2007-02-15
US8017146B2 (en) 2011-09-13
WO2003097020A1 (en) 2003-11-27
US20050208116A1 (en) 2005-09-22
EP1503743B1 (en) 2007-01-24
MXPA04011214A (es) 2005-11-04

Similar Documents

Publication Publication Date Title
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
AR097045A2 (es) Sistema terapéutico transdérmico
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
EA201070123A1 (ru) Устройство доставки в кожу с изолирующим слоем in situ
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
BRPI0116659B8 (pt) composição para uso em sistema de distribuição transdérmica de droga e sistema de distribuição transdérmica de droga
JP2005502430A5 (es)
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
ATE488228T1 (de) Klebstoffzubereitung
DE68924157D1 (de) Implantierte transdermale arzneimittel-verabreichungsanordnung.
AR004299A1 (es) Articulo absorbente descartable que incluye un area elastizada
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
ATE464888T1 (de) Vorrichtung für die transdermale abgabe von wirkstoffen
CA2637297A1 (en) Transdermal patch incorporating active agent migration barrier layer
DE602006003813D1 (de) Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
DE50310279D1 (de) Transdermalsystem mit fentanyl
NZ595549A (en) Transdermal therapeutic system containing nicotine
FI950165A0 (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
AR039137A1 (es) Unidad coherente de sistemas terapeuticos transdermicos separables
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
BR0008640A (pt) Dispositivo de administração transdérmica
DE50111208D1 (de) Matrixkontrolliertes transdermales system für stabile derivate der ace-hemmer
NO20031211L (no) Plaster omfattende diclofenac

Legal Events

Date Code Title Description
FB Suspension of granting procedure